quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:26:47·170d
INSIDERFiling
Cryo-Cell International Inc. logo

Chairman, Co-CEO Portnoy David was granted 9,666 shares, increasing direct ownership by 1% to 837,010 units (SEC Form 4)

CCEL· Cryo-Cell International Inc.
Health Care
Original source

Companies

  • CCEL
    Cryo-Cell International Inc.
    Health Care

Related

  • SEC9d
    SEC Form 10-Q filed by Cryo-Cell International Inc.
  • PR9d
    Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2026 Financial Results
  • SEC42d
    Cryo-Cell International Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR42d
    Cryo-Cell Receives NYSE American Continued Listing Notice
  • SEC55d
    SEC Form 10-K filed by Cryo-Cell International Inc.
  • PR55d
    Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025
  • INSIDER104d
    SEC Form 4 filed by Chairman, Co-CEO Portnoy David
  • INSIDER104d
    SEC Form 4 filed by Co-CEO Portnoy Mark L.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022